June 4, 2010 | Posted by susan.wilson@alston.com | Topic(s):
MAC Clauses
Javelin Pharmaceuticals, Inc. filed a lawsuit on Tuesday against Hospira, Inc., seeking to compel Hospira to consummate the acquisition of Javelin common stock pursuant to a tender offer as set forth in a merger agreement dated April 17, 2010. The lawsuit follows Hospira’s second extension of the closing date and its assertion that a MAC is reasonably expected.
Read More